Tata Chemicals Limited has announced its financial performance for the year ended March 31, 2026. The company reported a consolidated annual revenue of ₹14,584 crore. Despite significant challenges, including an impairment charge of ₹1,837 crore in the US business, the company continues its focus on core operations. The Board has recommended a final dividend of ₹11 per share (110%) for the 2025-26 fiscal year, subject to shareholder approval at the upcoming 87th Annual General Meeting.
Annual Financial Performance
For the financial year ended March 31, 2026, Tata Chemicals reported a consolidated revenue of ₹14,584 crore. The financial results were impacted by an exceptional item involving an impairment charge of ₹1,837 crore related to Goodwill in its US operations, driven by adverse market conditions and geopolitical factors. Consequently, the company recorded a consolidated net loss after tax of ₹1,715 crore for the year.
Segment Breakdown
The company operates across two primary segments: Basic Chemistry Products and Specialty Products. The Basic Chemistry segment generated ₹11,521 crore in revenue for the full year, while Specialty Products contributed ₹3,076 crore. The segment results highlight the operational challenges faced, with the Basic Chemistry division reporting a segment result loss of ₹1,311 crore, while the Specialty Products division remained profitable with a result of ₹168 crore.
Dividend Recommendation
Demonstrating commitment to its shareholders despite the challenging annual performance, the Board of Directors has recommended a final dividend of ₹11 per share for the financial year 2025-26. This dividend represents a 110% payout. The payment is subject to approval by the members at the upcoming 87th Annual General Meeting and is expected to be distributed within five days following the meeting, after accounting for applicable taxes.
Looking Ahead
The company continues to monitor its global business environment, including the impact of new Labour Codes in India, which resulted in a one-time incremental gratuity impact of ₹54 crore. Management remains focused on stabilizing operations, navigating geopolitical trade uncertainties, and driving efficiencies across both the Basic Chemistry and Specialty product portfolios to ensure sustainable growth in the coming periods.
Source: BSE
